Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 2 6Phase 1 4Phase 2/3 2Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 18Lymphoma 9Sarcoma 8Nausea 5Vomiting 4Lymphoma, Non-Hodgkin 4Carcinoma, Hepatocellular 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Recurrence 2Osteosarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Motor Activity 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Ewing 1Peritoneal Neoplasms 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

pegfilgrastim 1X-Rays 1Radiotherapy, Conformal 1Radiotherapy 1Ifosfamide 1Glutamine 1Fluorodeoxyglucose F18 1Doxorubicin 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Liposarcoma × Doxorubicin × Clear all
NCT00346125 2022-12-15

PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed
70 enrolled
Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡